GHRP-6 5mg ×10 + Ipamorelin 5mg ×10 (Bundle)
CAS: 87616-84-0 / 170851-70-4
The GHRP-6 & Ipamorelin 5mg ×10 Bundle by BioPeptides is a high-purity research peptide combination designed for advanced laboratory studies investigating ghrelin receptor signaling, growth hormone release pathways, and endocrine system regulation. Manufactured using precision solid-phase peptide synthesis (SPPS) and purified to ≥99% HPLC purity, this peptide bundle enables researchers to explore receptor selectivity, signaling efficiency, and hormonal pathway coordination in controlled in-vitro research environments.
$118.00
Research Use Only
Research Overview
The GHRP-6 & Ipamorelin bundle is designed for laboratory research investigating ghrelin receptor signaling and growth hormone release pathways.
GHRP-6 is a growth hormone secretagogue peptide studied for its strong interaction with the ghrelin receptor (GHS-R).
Ipamorelin is a selective ghrelin receptor agonist commonly studied for its targeted signaling profile and controlled endocrine pathway activation.
Studying these peptides together allows researchers to analyze receptor sensitivity, signal amplitude, and endocrine feedback mechanisms.
Scientific Background
Growth hormone release is regulated through receptor-mediated endocrine signaling pathways.
GHRP-6 stimulates ghrelin receptors which influence GH secretion signaling.
Ipamorelin activates the same receptor family but with higher signaling selectivity.
Using these peptides together allows scientists to investigate receptor sensitivity, pathway efficiency, and endocrine signaling coordination.
Mechanistic Research Perspective
- Ghrelin receptor (GHS-R) activation analysis
- Growth hormone release signaling pathway research
- Endocrine feedback loop investigation
- Ligand-receptor interaction modeling
- Comparative secretagogue pathway analysis
Primary Research Applications
Growth Hormone Secretion Dynamics: Researchers investigate GH release patterns, receptor activation thresholds, and hormonal signaling efficiency.
Ghrelin Receptor Binding Research: Scientists examine receptor affinity, ligand selectivity, and downstream intracellular signaling cascades.
Endocrine Pathway Modeling: Laboratories study how different secretagogue peptides influence endocrine system regulation.
Cellular Signaling Research: The peptide combination is used in cell-based experiments analyzing transcriptional responses and intracellular signaling.
In-Vitro Research Models: This bundle is frequently incorporated into non-clinical laboratory models investigating endocrine signaling mechanisms.
Molecular Characteristics
- Peptide Type: Growth hormone secretagogues
- GHRP-6 CAS: 87616-84-0
- Ipamorelin CAS: 170851-70-4
- Form: Lyophilized peptide powder
- Purity: ≥99% HPLC verified
Stability Profile and Storage Recommendations
- Store lyophilized peptides at −20°C
- Protect from moisture and direct light
- Avoid repeated freeze-thaw cycles
- Reconstituted solutions should be refrigerated
- Handle under aseptic laboratory conditions
Solubility and Reconstitution Options
- Sterile bacteriostatic water
- Sterile saline solutions
- Buffered aqueous laboratory solutions
- Biochemical assay buffers
- Laboratory-grade solvent systems
Technical Specifications
product Name
GHRP-6 + Ipamorelin Bundle
brand
BioPeptides
cas
87616-84-0 / 170851-70-4
purity
≥99% (HPLC verified)
unit Size
5mg ×10 vials each
form
Lyophilized powder
synthesis
Solid-Phase Peptide Synthesis (SPPS)
analytical
HPLC, Mass Spectrometry
molecular Structure
Synthetic peptide hormones
stability
High when stored at −20°C
Analytical Validation and Quality Assurance
- High-performance liquid chromatography purity verification
- Mass spectrometry molecular weight confirmation
- Peptide structural integrity testing
- Batch-to-batch analytical consistency
- Peptide stability validation
Frequently Asked Questions
The bundle allows researchers to study both strong and selective ghrelin receptor activation, enabling detailed analysis of signaling intensity, receptor sensitivity, and endocrine pathway coordination.
GHRP-6 produces strong receptor activation and robust GH signaling, while Ipamorelin is studied for its selective receptor engagement and targeted endocrine signaling.
Yes. The 5mg ×10 vial configuration supports extended research programs while minimizing peptide degradation risk.
Yes. Researchers often use this bundle to compare receptor sensitivity, ligand selectivity, and downstream signaling behavior.
Yes. Each peptide is supplied in separate vials allowing precise experimental design and improved stability.
Lyophilized peptides should be stored at −20°C and reconstituted using sterile laboratory solvent.
BioPeptides is trusted by European laboratories for high-purity peptide synthesis, verified CAS documentation, and consistent research-grade quality.